An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database.
Not Applicable
Recruiting
- Conditions
- Esophageal cancer or esophagogastric cancer
- Registration Number
- JPRN-UMIN000050925
- Lead Sponsor
- Japanese Foundation For Cancer Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1750
Inclusion Criteria
Not provided
Exclusion Criteria
Cases of esophageal cancer other than squamous cell carcinoma or adenocarcinoma, have not been treated with neoadjuvant therapy, and that resulted in R1 or R2 resection.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method